Search
Lumexa Imaging Holdings Ord Shs
LMRIAdd to Watchlist
12.430USD
+0.840+7.25%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.19BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
8
analysts
Strong Buy
Current Rating
17.167
Target Price
+38.11%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
68
Total
8
Median
8
Average
Company name
Ratings
Analysts
Lumexa Imaging Holdings Ord Shs
LMRI
8
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
26
Teladoc Health Inc
TDOC
26
Natera Inc
NTRA
24
Tenet Healthcare Corp
THC
23
1
2
3
...
14
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Lumexa Imaging Holdings Ord Shs's expected revenue for the next quarter?
Lumexa Imaging Holdings Ord Shs's expected revenue is 271.15M.
How have Lumexa Imaging Holdings Ord ShsLMRI's recent earnings per share performed?
The market expectation was USD 0.02, while Lumexa Imaging Holdings Ord ShsLMRI's earnings per share (EPS) for the previous quarter was USD -0.28. EPS for the next quarter is expected at USD 0.16.
What is the analyst rating for Lumexa Imaging Holdings Ord Shs?
Based on the ratings of Lumexa Imaging Holdings Ord Shs's stock from 8 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.